AIIMS Bhubaneswar Sickle Cell Blood Group Study Recruitment 2026: PTS-III, PG Eligibility Route

# AIIMS Bhubaneswar Sickle Cell Antigen Study 2026: One PTS-III Contract Vacancy

AIIMS Bhubaneswar has one Project Technical Support-III vacancy in a separate ICMR-funded multicentre study of clinically important blood-group antigens and alloimmunisation risk among patients with sickle cell disease. The qualifying degree and work-experience pathways differ materially: a three-year graduate degree in a relevant field WITH three post-qualification years, OR a relevant postgraduate qualification. The prescribed-form email deadline is 23 October 2026 at 5 PM, while the 31 October 10:30 AM interview is tentative. The published monthly consolidated amount is Rs 33,600 INCLUDING Rs 5,600 HRA, not Rs 33,600 plus HRA.

## This is a separate ICMR advertisement despite the shared 23 October email cutoff

This notice has its own E-file number **TMBB-18/5/2026-TMBB DEPT**, was dated **1 October 2026** and was separately listed on the institute's recruitment page on 8 October. Principal investigator Dr Somnath Mukherjee and the Department of Transfusion Medicine own the project identity. The single PTS-III vacancy is **not** a fourth post inside the 13 October PERFUSE-AKI Anaesthesiology notice. Each advertisement has its own source PDF, subject instruction, stipend structure, 11- versus 6-month service term and addressee. Both do close for email submissions on 23 October, so applicants considering both must handle their forms and communications independently.

## Which academic route qualifies: 3-year graduate degree plus experience, or PG

The essential column states **(a) a three-year graduate degree in a relevant subject/field + three years' post-qualification experience OR (b) PG in the relevant subject/field**. The three years are tied to the undergraduate route, and the PG route is an explicit alternative rather than a demand for both a graduate degree and three additional years. The study context does not justify fabricating one mandatory named degree such as BSc MLT, MD or MSc Biochemistry: the PDF says **relevant subject/field**, with relevance assessed by the recruiting institute. An applicant should describe the subject modules and past work that establish laboratory or clinical-research relevance. A candidate with the qualifying 3-year undergraduate route needs dated employer documents proving the three years AFTER the qualification, not only a résumé entry. A PG-route candidate must prove the PG is in the relevant discipline; a generic unrelated PG should not be presented as automatically accepted.

## What blood-bank assays signal—and why they are desirable rather than a new eligibility barrier

The desirable column explicitly names hands-on work in pathology, biochemistry or a blood bank; drawing blood; ELISA; immunohaematology; blood grouping, cross-matching and Coombs testing. These details make this more than a generic PTS vacancy. An otherwise eligible postgraduate applicant can highlight actual validated laboratory procedures, quality-control logs or study/sample documentation, but should not falsely claim a professional certification, transfusion-related licence or mandatory ELISA examination absent from the notification. Blood collection and serological methods are **desirable background**, not all individually essential documents. The notice does not publish an exhaustive day-to-day responsibility list, so descriptions here distinguish advertised competencies from possible programme activity.

## Clinical context from the Ministry of Health: antigen matching and alloimmunisation risk

The National Health Mission's official Guidelines on Hemoglobinopathies discuss extended red-cell antigen typing and clinically significant antibodies in transfusion care for sickle cell disease. That background helps explain why a multicentre project assessing antigen frequency and alloimmunisation risk requires laboratory-quality documentation: reporting a result with the wrong antigen terminology or specimen identity could compromise interpretation. It does **not** convert the guideline into a recruitment-eligibility notice or authorize invented responsibilities such as performing particular tests without supervision. The project evaluates blood-group antigen epidemiology; the original employer advertisement alone controls candidate qualification, contract and deadlines. Background guidance: https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/Guidelines_on_Hemoglobinopathies_in%20India.pdf.

## Pay is Rs 33,600 inclusive—not an additional HRA entitlement

The PDF explicitly calculates **Rs 28,000/month plus 20% HRA (Rs 5,600) = Rs 33,600 consolidated per month**. Unlike PERFUSE-AKI's separate base-plus-HRA schedule, the Rs 33,600 figure is already the arithmetic total here. If a website displays Rs 33,600 plus 20% again it has double-counted accommodation allowance. This is not a 7th CPC regular basic-pay scale and does not establish net salary. Appointment is initially for **11 months**, and any extension is conditional on agency funding, project need, satisfactory performance and institute approval; it is not an assured one-year permanent job.

## Actual age reference is interview day, and the schedule itself may change

Maximum age for this PTS-III notice is **35 years**. Clause 8 says age is calculated on the **date of Walk-In-Interview**, not on 23 October when emails close. The advertisement calls **31 October 2026, 10:30 AM** a *tentative* walk-in date. Therefore 31 October is not a fixed, unconditional age-reference date if the interview is rescheduled. An applicant should confirm the interview date before treating any particular calendar day as the age cut-off. Unquantified SC/ST/OBC/PWD concessions may apply under government provisions; the PDF provides no exact relaxation-year breakdown. In contrast, the accompanying PERFUSE-AKI notice does fix the age-reference date to the 23 October application deadline.

## The email subject is unusually long and project-specific

The approved standard-format application must reach **tranmed_somnath@aiimsbhubaneswar.edu.in** by **23 October 2026, 5:00 PM IST**. The advertisement instructs candidates to use a subject beginning **Application for the post of Project Technical Support-III sanctioned under ICMR project entitled** and then identifying the full sickle-cell blood-group/alloimmunisation project. The useful action is to preserve this project identity in the email subject rather than send a vague subject like "Job Application". No hard copy is needed when first emailing the form. Shortlisted candidates are informed by email and called for walk-in; the candidate should retain sent-message and attachment confirmation. An email to the separate Anaesthesiology address is **not** a valid substitute. Late, incomplete or non-prescribed formats are expressly rejected.

## Contract exit obligations are not symmetrical in practical effect

The termination clause discusses one month's notice from either side and a payment equivalent to one month's contractual amount for ending a contract early, but it expressly **does not permit the appointee simply to pay and skip the unserved notice**. Contractual workers weighing this 11-month role against another fellowship, residency or faculty appointment should budget for that exit restriction. Regular government time-scale service applicants are specifically excluded; PF, pension, LTC and medical claims of regular AIIMS employees are not offered. Successful applicants must show original degrees, age proof, dated experience certificates, valid identity proof, photograph and self-attested copies at joining; missing originals or discrepancies may lead to an offer passing to the waitlist.

## How to decide between the two distinct 23 October AIIMS Bhubaneswar notices

For an applicant with a **relevant PG but no documented 3-year experience**, this PTS-III advert expressly provides a PG route. PERFUSE-AKI Scientist-II, by contrast, requires relevant PG plus three years OR PhD. For an applicant with **Science Class 12, MLT/DMLT and five years**, the PERFUSE-AKI PTS-II route fits its essential text; those credentials should not be misrepresented as automatically satisfying this separate PTS-III three-year degree-or-PG route. The salary and term differ: PTS-III has an HRA-inclusive Rs 33,600 monthly total and 11 months initially; PTS-II has Rs 20,000/month plus separately stated 20% HRA and 6 months initially. Also compare age: 35 at interview versus 30 as of 23 October. Both require advance email by 5 PM on 23 October, but each has its own form, PI and recipient.

## Original sources and unresolved details to check before sending the email

The original 7-page application notice, departmental terms and prescribed form are https://aiimsbhubaneswar.nic.in/wp-content/uploads/2026/10/e5cf7478-70b8-4754-b7a7-9b4db67f40cd.pdf, and the AIIMS Research Project Recruitment listing is https://aiimsbhubaneswar.nic.in/category_recrutimentnotice/research-project-recruitment/. The separate PERFUSE-AKI PDF is https://aiimsbhubaneswar.nic.in/wp-content/uploads/2026/10/Recruitment-Notice.pdf. This document does not state a numeric fee or fixed written-test format. The 31 October walk-in is tentative, while the email closing time is certain. It does not publish a category-wise vacancy split for its single seat, an exact minimum age, a guaranteed extension date or any mandatory score threshold. Applicants should confirm any institute-published corrigendum before attending. No third-party website should replace the original PDF for eligibility or application instructions.